C-peptide improves autonomic nerve function in IDDM patients

Diabetologia

Volumn 39, Issue 6, 1996, Pages 687-695

  Johansson, B L ^a   Borg, K ^a   Fernqvist Forbes, E ^a   Odergren, T ^a   Remahl, S ^a   Wahren, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acceleration index; Brake index; Diabetic polyneuropathy; Expiration inspiration; Nerve conduction velocity; Quantitative somatosensory thresholds; Ratio; Vibrametry

Indexed keywords

C PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NERVE CONDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029890303     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00418540     Document Type: Article

References (41)

1. Melton LJ, Dyck PJ (1987) Epidemiology. In: Dyck PJ, Thomas PK, Asbury AK, Winegard AI, Porte Jr (eds) Diabetic neuropathy. W. B. Saunders, Philadelphia, pp 27-35
2. Ewing DJ, Clarke BF (1986) Diabetic autonomie neuropathy: present insights and future prospects. Diabetes Care 9: 648-665
3. Thomas PK (1991) Diabetic neuropathy: epidemiology and pathogenesis. In: Pickup JC, Williams G (eds) Textbook of diabetes, Vol 2. Blackwell Scientific Publications, Oxford, pp 613-622
4. Greene DA, Yagihashi S, Lattimer SA, Sima AAF (1984) Nerve Na + K + ATPase, conduction and myo-inositol in the insulin dependent BB rat. Am J Physiol 247: 534-539
5. Raccah D, Gallice P, Pouget J, Vague P (1992) Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy. Diabete Metab 18: 236-241
6. Steiner D (1978) On the role of the proinsulin C-peptide. Diabetes 27: [Suppl 1] 141-148
7. Johansson B-L, Sjöberg S, Wahren J (1992) The influence of C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 121-128
8. Johansson B-L, Kernell A, Sjöberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77: 976-981
9. Johansson B-L, Linde B, Wahren J (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm in type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 1151-1158
10. Ohtomo Y, Aperia A, Sahlgren B, Johansson B-L, Wahren J (1996) C-peptide stimulates rat renal tubular Na + K + -ATPase activity in synergism with neuropeptide. Diabetologia 39: 199-205
11. American Diabetes Association, American Academy of Neurology (1988) Consensus statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 11: 592-597
12. Dyck PJ (1988) Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11: 21-32
13. Sundkvist G, Almér L-O, Lilja B (1979) Respiratory influence on heart rate in diabetes mellitus. BMJ 1: 924-925
14. Sundkvist G, Almér L-O, Lilja B (1980) Abnormal diastolic blood pressure and heart rate reactions to tilting in diabetes mellitus. Diabetologia 19: 433-438
15. Bergström B, Lilja B, Rosberg K, Sundkvist G (1986) Autonomic nerve function tests. Reference values in healthy subjects. Clin Physiol 6: 523-528
16. Hansson P, Lindblom U, Lindström P (1991) Graded assessment and classification of impaired temperature sensibility in patients with diabetic polyneuropathy. J Neurol Neurosurg Psychiatr 54: 527-530
17. Frusthorfer H, Lindblom U, Schmidt WG (1976) Method for quantitative estimation of thermal threshold in patients. J Neurol Neurosurg Psychiatr 39: 1071-1075
18. Lindblom U (1981) Quantitative testing of sensibility including pain. In: Stålberg SE, Young RR (eds) Clinical neurophysiology, neurology 1. Butterworth, London, pp 168-190
19. Goldberg JM, Lindblom U (1979) Standardized method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatr 42: 793-803
20. Ziegler D. Mayer P, Gries FA (1988) Evaluation of thermal, pain and vibration sensation in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatr 51: 1420-1424
21. Arnqvist H, Olson PO, Von Schenk H (1987) Free and total insulin determined after precipitation with polyethylene glycol: analytic characteristics and effects of sample handling and storage. Clin Chem 33: 93-96
22. The Diabetic Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
23. Reichard P, Nilsson B-Y, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304-309
24. Fedele D, Negrin P, Cardone C et al. (1984) Influence of continuous subcutaneous insulin infusion (CSII) treatment on diabetic somatic and autonomic neuropathy. J Endocrinol Invest 7 (6): 623-628
25. Sundkvist G, Lilja B, Rosén I, Agardh C-D (1987) Autonomic and peripheral nerve function in early diabetic neuropathy. Possible influence of a novel aldose reductase inhibitor on autonomic function. Acta Med Scand 221: 445-453
26. Jaspan JB, Herold K, Bartkus C (1985) Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy. Am J Med 79: [Suppl 5A] 24-37
27. Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS (1990) Effects of pancreatic transplantation on diabetic neuropathy. New Engl J Med 322: 1031-1037
28. Solders G, Tyden G, Persson A, Groth C-G (1992) Improvement of nerve conduction in diabetic neuropathy - a follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes 41: 948-951
29. Nusser J, Scheuer R, Abendroth D, Illner W-D, Land W, Landgraf R (1991) Effect of pancreatic and/or renal transplantation on diabetic autonomic neuropathy. Diabetologia 34: [Suppl 1] 118-120
30. Guy RJC, Clark CA, Malcom PN, Watkins PI (1985) Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia 28: 131-137
31. Navarro X, Kennedy WR (1991) Evaluation of thermal and pain sensitivity in type 1 diabetic patients. J Neurol Neurosurg Psychiatr 54: 60-64
32. Fagius J, Wahren LK (1981) Variability of sensory threshold determination in clinical use. J Neurol Sci 51: 11-27
33. Watkins PJ (1992) Clinical observations and experiments in diabetic neuropathy. Diabetologia 35: 2-11
34. Williams E, Timperley WR, Ward JD, Duckworth T (1980) Electron microscopical studies of vessels in diabetic neuropthy. J Clin Pathol 33: 462-70
35. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R (1986) Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19: 425-439
36. Tesfaye S, Harris ND, Wilson RM, Ward JD (1992) Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy. Diabetologia 35: 155-159
37. Young RJ, Macintyre CCA, Martyn CN et al. (1986) Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: associations with glycemic control and microangiopathy (microvascular complications). Diabetologia 29: 156-161
38. Lindström K, Johansson C, Johansson E, Haraldsson B (1996) Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscles and kidneys in rat. Acta Physiol Scand 156: in press
39. Daube J, Service FJ, Dyck PJ (1980) Acute effects on nerve conduction of strict control of blood sugar with an artificial pancreas. Muscle Nerve 9: 347
40. The St. Thomas Diabetic Study Group (1986) Failure of improved glycaemic control to reverse diabetic autonomic neuropathy. Diabet Med 3: 330-334
41. Johansson B-L, Fernqvist-Forbes E, Wahren J (1995) Effects of C-peptide on nephropathy and neuropathy in IDDM patients - a clinical study. Diabetes 44: [Suppl 1] 33 A (Abstract)